IVSD Stock Overview
A private equity firm specializing in mature, middle market, buyouts and growth capital investments. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Investor AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 25.89 |
| 52 Week High | SEK 28.25 |
| 52 Week Low | SEK 18.78 |
| Beta | 0.76 |
| 11 Month Change | -4.02% |
| 3 Month Change | -3.77% |
| 1 Year Change | 36.15% |
| 33 Year Change | 23.20% |
| 5 Year Change | 117.93% |
| Change since IPO | 1,226.93% |
Recent News & Updates
Recent updates
Shareholder Returns
| IVSD | DE Diversified Financial | DE Market | |
|---|---|---|---|
| 7D | 1.7% | -3.3% | 1.3% |
| 1Y | 36.2% | 2.9% | 7.9% |
Return vs Industry: IVSD exceeded the German Diversified Financial industry which returned 1.9% over the past year.
Return vs Market: IVSD exceeded the German Market which returned 7.2% over the past year.
Price Volatility
| IVSD volatility | |
|---|---|
| IVSD Average Weekly Movement | 2.6% |
| Diversified Financial Industry Average Movement | 3.6% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.8% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: IVSD has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: IVSD's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1916 | 18,795 | Christian Cederholm | www.investorab.com |
Investor AB (publ) is a private equity firm specializing in mature, middle market, buyouts and growth capital investments. For core investments, the firm invests in health care, financial services, IT and fintech sectors and considers investments in listed companies in leading minority positions. The firm seeks to invest globally.
Investor AB (publ) Fundamentals Summary
| IVSD fundamental statistics | |
|---|---|
| Market cap | €78.92b |
| Earnings (TTM) | €17.78b |
| Revenue (TTM) | €23.00b |
4.4x
P/E Ratio3.4x
P/S RatioIs IVSD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IVSD income statement (TTM) | |
|---|---|
| Revenue | SEK 265.08b |
| Cost of Revenue | SEK 32.77b |
| Gross Profit | SEK 232.31b |
| Other Expenses | SEK 27.33b |
| Earnings | SEK 204.98b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Jan 23, 2025
| Earnings per share (EPS) | 66.92 |
| Gross Margin | 87.64% |
| Net Profit Margin | 77.33% |
| Debt/Equity Ratio | 11.2% |
How did IVSD perform over the long term?
See historical performance and comparison